天康生物(002100) - 2020 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2020 was ¥1,983,537,035.47, representing a 64.63% increase compared to ¥1,204,813,855.90 in the same period last year[10] - Net profit attributable to shareholders was ¥334,552,715.62, a significant increase of 1,056.82% from ¥28,920,108.83 in the previous year[10] - Basic earnings per share were ¥0.31, up 933.33% from ¥0.03 in the same period last year[10] - The net profit attributable to the parent company reached CNY 334.55 million, reflecting a year-on-year growth of 1056.82%, driven by a significant increase in pork prices in the national market[23] - Net profit for Q1 2020 reached CNY 325,628,705.24, compared to a mere CNY 24,117.73 in Q1 2019, indicating a substantial improvement in profitability[69] - Total comprehensive income attributable to the parent company is ¥334,552,715.62, up from ¥28,920,108.83, showing a remarkable increase[72] Cash Flow - The net cash flow from operating activities reached ¥510,611,919.66, marking a 421.58% increase from ¥97,896,377.87 in the same period last year[10] - The net cash flow from operating activities was 307,431,927.32, a significant improvement compared to -9,605,854.12 from the previous period[87] - Cash inflow from operating activities totaled 382,316,072.17, down 22.6% from 494,327,854.80 in the prior period[87] - The net cash flow from investing activities was 23,041,892.88, a recovery from -315,436,767.52 in the prior period[90] - The company reported a cash increase of 283,220,985.13 during the period, compared to 174,908,275.25 in the previous period[86] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,609,154,321.49, an increase of 4.08% from ¥11,154,464,066.40 at the end of the previous year[10] - The total liabilities of the company reached CNY 6.09 billion, compared to CNY 5.99 billion, marking an increase of approximately 1.67%[51][54] - Total liabilities amounted to CNY 5,989,645,710.31, with current liabilities at CNY 4,300,955,352.67 and non-current liabilities at CNY 1,688,690,357.64[97] - The company's total equity was CNY 5,164,818,356.09, with equity attributable to shareholders of the parent company at CNY 4,592,802,200.06[97] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 65,925[14] - The largest shareholder, Xinjiang Production and Construction Corps, held 26.58% of the shares[14] Research and Development - Research and development expenses increased by 74.47% year-on-year to CNY 22.02 million, indicating a stronger focus on R&D investment[22] - Research and development expenses for Q1 2020 were CNY 22,020,019.72, compared to CNY 12,620,993.58 in the previous year, highlighting an increased focus on innovation[66] - Research and development expenses increased significantly to ¥18,139,174.00, up from ¥10,086,016.17, marking an increase of about 80.2%[73] Financial Management - The company's financial expenses increased by 30.09% year-on-year to CNY 55.08 million, primarily due to a rise in loan balances[22] - The company incurred financial expenses of ¥15,000,078.63, down from ¥16,753,346.01, which is a decrease of approximately 10.5%[73] Operational Highlights - The company's operating revenue for the reporting period was CNY 1,983.54 million, an increase of 64.63% year-on-year, primarily due to higher sales prices in the food farming business and expanded sales in the feed business[22] - Total operating costs for Q1 2020 were CNY 1,619,680,424.18, up from CNY 1,184,475,340.91, reflecting a significant increase in operating expenses[66] - The company reported a gross profit margin improvement, with gross profit for Q1 2020 at CNY 613,856,611.29, compared to CNY 219,281,515.99 in Q1 2019[66] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[60] - The company is implementing new revenue and leasing standards starting in 2020, which may impact future financial reporting[102]